G230249-NCT06096337

Dynamic List Information
Dynamic List Data
Study Title
A Prospective Randomized Multicenter Global Study Comparing Pulsed Field Ablation (PFA) Versus Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
Sponsor Name
Boston Scientific Corporation
NCT Number
NCT06096337
IDE Number
G230249
CMS Approval Date
2023-12-20
Category
B